"Heroin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed)
| Descriptor ID |
D003932
|
| MeSH Number(s) |
D03.132.577.249.562.445 D03.605.497.607.490 D03.633.400.686.607.490 D04.615.723.795.576.445
|
| Concept/Terms |
Heroin- Heroin
- Diacetylmorphine
- Diamorphine
Heroin Hydrochloride- Heroin Hydrochloride
- Hydrochloride, Heroin
- Diacetylmorphine Hydrochloride
- Hydrochloride, Diacetylmorphine
|
Below are MeSH descriptors whose meaning is more general than "Heroin".
Below are MeSH descriptors whose meaning is more specific than "Heroin".
This graph shows the total number of publications written about "Heroin" by people in this website by year, and whether "Heroin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heroin" by people in Profiles.
-
Benau EM, Zavodnick JH, Jaffe RC. Initial evidence of reliability and validity of an implicit association test assessing attitudes toward individuals who use substances. Am J Drug Alcohol Abuse. 2024 01 02; 50(1):64-74.
-
D'Orazio J, Nelson L, Perrone J, Wightman R, Haroz R. Xylazine Adulteration of the Heroin-Fentanyl Drug Supply : A Narrative Review. Ann Intern Med. 2023 10; 176(10):1370-1376.
-
Kacinko SL, Mohr ALA, Logan BK, Barbieri EJ. Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework. J Anal Toxicol. 2022 Oct 14; 46(8):911-917.
-
Calello DP, Aldy K, Jefri M, Nguyen TT, Krotulski A, Logan B, Brent J, Wax P, Walton S, Manini AF. Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose. Clin Toxicol (Phila). 2022 09; 60(9):1067-1069.
-
Reed MK, Salcedo VJ, Guth A, Rising KL. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs. J Subst Abuse Treat. 2022 09; 140:108790.
-
Reed MK, Guth A, Salcedo VJ, Hom JK, Rising KL. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs. Int J Drug Policy. 2022 05; 103:103643.
-
Krotulski AJ, Chapman BP, Marks SJ, Ontiveros ST, Devin-Holcombe K, Fogarty MF, Trieu H, Logan BK, Merchant RC, Babu KM. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose. Clin Toxicol (Phila). 2022 Feb; 60(2):197-204.
-
Midthun KM, Nelson LS, Logan BK. Levamisole-a Toxic Adulterant in Illicit Drug Preparations: a Review. Ther Drug Monit. 2021 04 01; 43(2):221-228.
-
Carlier J, La Maida N, Di Trana A, Huestis MA, Pichini S, Busard? FP. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Ther Drug Monit. 2020 04; 42(2):205-221.
-
Voelker J, Maio V, Mammen P. Changing the Narrative: Refocusing the Efforts of Emergency Departments in the Opioid Epidemic. Am J Med Qual. 2018 07; 33(4):345-347.